Prediction of Transporter‐Mediated Drug‐Drug Interactions for Baricitinib

Baricitinib, an oral selective Janus kinase 1 and 2 inhibitor, undergoes active renal tubular secretion. Baricitinib was not predicted to inhibit hepatic and renal uptake and efflux drug transporters, based on the ratio of the unbound maximum eliminating‐organ inlet concentration and the in vitro ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Posada, Maria M., Cannady, Ellen A., Payne, Christopher D., Zhang, Xin, Bacon, James A., Pak, Y. Anne, Higgins, J. William, Shahri, Nazila, Hall, Stephen D., Hillgren, Kathleen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402191/
https://www.ncbi.nlm.nih.gov/pubmed/28749581
http://dx.doi.org/10.1111/cts.12486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402191/
https://www.ncbi.nlm.nih.gov/pubmed/28749581
http://dx.doi.org/10.1111/cts.12486

Ejemplares similares